HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,177-1,188 of 4,505
Drug study icon
CompletedNCT01614912

Long-term Extension Study of SM-13496 (Lurasidone HCl) in people with Schizophrenia

What is this study about?

Researchers studied SM-13496 to find out how it affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Tokyo, Etc
SchizophreniaMedication studyAges 18–74
Countries
Japan, Malaysia, South Korea, + 1 other
Sponsor
Sumitomo Pharma Co., Ltd.
Drug study icon
CompletedNCT01244828

Asenapine for schizophrenia

Official study title

Long-term Study of Asenapine in Subjects With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (Protocol P06238)

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaMedication studyAges 20+
Countries
Sponsor
Organon and Co
Drug study icon
CompletedNCT01626872

Long-Term Study of MP-214 in people with Schizophrenia

Official study title

Long-Term Extension Study of MP-214 in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Sapporo
SchizophreniaMedication studyAges 20–65
Countries
Japan, South Korea, Taiwan
Sponsor
Tanabe Pharma Corporation
Behavioral study icon
WithdrawnNCT05469815

Lost Children Society (LCS), Online Therapeutic Tabletop Role-playing Game for Early-onset Schizophrenia Patients

Official study title

Lost Children Society (LCS), Metacognitive Training Integrated Into an Online Therapeutic Tabletop Role-playing Game for Early-onset Schizophrenia Patients : a Pilot Study on Feasibility

This study was withdrawn before enrollment.

Remote / online
SchizophreniaBehavioural studyAges 15–20
Countries
Sponsor
Centre Hospitalier Departemental Vendee
Other study type icon
CompletedNCT02175251

Low and High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Resistant Auditory Hallucination in Schizophrenia

Official study title

Low and High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Resistant Auditory Hallucination in Schizophrenia: a Double Blind Sham-controlled Randomised Study

This study has finished and is no longer accepting participants.

In Colombes
SchizophreniaInterventional studyAges 18+
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Drug study icon
CompletedNCT04959032

Lumateperone for the Prevention of Relapse in people with Schizophrenia

Official study title

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–60
Countries
United States, Bulgaria, Poland, + 1 other
Sponsor
Intra-Cellular Therapies, Inc.
Other study type icon
CompletedNCT06527885

Lurasidone Non-Interventional Study in Schizophrenia Patients

Official study title

Treatment Satisfaction and Effectiveness of Lurasidone on Quality of Life and Functioning in Adult Patients With Schizophrenia Treated in the Real World Italian Clinical Practice

This study has finished and is no longer accepting participants.

Multiple locations, including Brescia
SchizophreniaObservational studyAges 18–99
Countries
Italy
Sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.